SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052524
Filing Date
2020-11-09
Accepted
2020-11-09 16:21:00
Documents
77
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alt-10q_20200930.htm 10-Q 1842665
2 EX-10.1 alt-ex101_236.htm EX-10.1 29273
3 EX-10.2 alt-ex102_237.htm EX-10.2 14641
4 EX-31.1 alt-ex311_8.htm EX-31.1 18173
5 EX-31.2 alt-ex312_6.htm EX-31.2 17906
6 EX-32.1 alt-ex321_10.htm EX-32.1 6192
7 EX-32.2 alt-ex322_11.htm EX-32.2 6146
8 GRAPHIC gqh5kkem4z5h000001.jpg GRAPHIC 6605
  Complete submission text file 0001564590-20-052524.txt   6433285

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT alt-20200930.xml EX-101.INS 1221193
10 XBRL TAXONOMY EXTENSION SCHEMA alt-20200930.xsd EX-101.SCH 53237
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alt-20200930_cal.xml EX-101.CAL 57358
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alt-20200930_def.xml EX-101.DEF 155771
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20200930_lab.xml EX-101.LAB 425657
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20200930_pre.xml EX-101.PRE 316494
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 201297965
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences